Imiquimod-induced bullous pemphigoid: A case report

被引:1
作者
Li, Heidi Oi-Yee [1 ,2 ]
Aw, Michael [2 ]
Glassman, Steven J. [1 ,3 ,4 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Div Dermatol, Ottawa, ON, Canada
[2] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[3] Univ Ottawa, Div Dermatol, 4th Floor,737 Parkdale Ave, Ottawa, ON K1Y 1J8, Canada
[4] Ottawa Hosp, Civ Parkdale Clin, 4th Floor,737 Parkdale Ave, Ottawa, ON K1Y 1J8, Canada
来源
SAGE OPEN MEDICAL CASE REPORTS | 2023年 / 11卷
关键词
Bullous pemphigoid; imiquimod; actinic keratoses;
D O I
10.1177/2050313X231164222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.
引用
收藏
页数:3
相关论文
共 11 条
  • [1] Ameglio F, 1998, BRIT J DERMATOL, V138, P611
  • [2] Scabies masquerading as bullous pemphigoid: scabies surrepticius
    Cohen, Philip R.
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2017, 10 : 317 - 324
  • [3] Analysis of 6 cases of drug-induced pemphigus
    Feng, Suying
    Zhou, Wuqing
    Zhang, Jiechen
    Jin, Peiying
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (05) : 696 - 699
  • [4] Long-term interferon-alpha therapy induces autoantibodies against epidermis
    Fleischmann, M
    Celerier, P
    Bernard, P
    Litoux, P
    Dreno, B
    [J]. DERMATOLOGY, 1996, 192 (01) : 50 - 55
  • [5] New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
    Genovese, Giovanni
    Di Zenzo, Giovanni
    Cozzani, Emanuele
    Berti, Emilio
    Cugno, Massimo
    Marzano, Angelo Valerio
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [6] Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3
    Iriki, Hisato
    Mukai, Miho
    Ito, Hiromi
    Kurebayashi, Yutaka
    Amagai, Masayuki
    Takahashi, Hayato
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 100 (03) : 166 - 174
  • [7] Case Report: Bullous Scabies
    Luo, Di-Qing
    Huang, Mei-Xing
    Liu, Juan-Hua
    Tang, Wen
    Zhao, Yu-Kun
    Sarkar, Rashmi
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (03) : 689 - 693
  • [8] Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
    Mai, Yosuke
    Nishie, Wataru
    Sato, Kazumasa
    Hotta, Moeko
    Izumi, Kentaro
    Ito, Kei
    Hosokawa, Kazuyoshi
    Shimizu, Hiroshi
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment
    Mashiah, J
    Brenner, S
    [J]. ARCHIVES OF DERMATOLOGY, 2005, 141 (07) : 908 - 909
  • [10] Verheyden M., 2020, ACTA DERM-VENEREOL, V100